NasdaqGS - Nasdaq Real Time Price USD

IDEXX Laboratories, Inc. (IDXX)

509.42

+0.29

+(0.06%)

At close: May 14 at 4:00:01 PM EDT

508.42

-1.00

(-0.20%)

Pre-Market: 5:37:40 AM EDT

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

Here is how Idexx Laboratories (IDXX) and AngioDynamics (ANGO) have performed compared to their sector so far this year.

Zacks 21 hours ago

IDXX
+0.06%

ANGO
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

WESTBROOK, Maine, May 13, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financial Officer, and Tina Hunt, Executive Vice President, Global Strategy and Commercial, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 28, 2025 from 10:55 am – 11:25 am (EDT).

Business Wire yesterday

IDXX
+0.06%
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX)

Baron Funds, an investment management firm, released its “Focused Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Q1 was a difficult start to the year. The fund declined 7.95% (Institutional Shares) in the quarter, compared to the Russell 2500 Growth Index’s (the Benchmark) 10.80% return. Please spare […]

Insider Monkey 6 days ago

IDXX
+0.06%
Idexx Laboratories price target raised to $460 from $420 at Stifel

Stifel raised the firm’s price target on Idexx Laboratories (IDXX) to $460 from $420 and keeps a Hold rating on the shares. The firm says that the company’s Q1 results were not surprising, but the stock’s reaction was a bit stronger than expected. Stifel will continue to monitor the uptake of Cancer Dx and inVue, but for now the firm believes the near-term contribution is already reflected in estimates. Published first on TheFly – the ultimate source for real-time, market-moving breaking financi

TipRanks 12 days ago

IDXX
+0.06%
IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS

IDEXX Laboratories (NasdaqGS:IDXX) experienced a 13% price increase over the last month, spurred by robust first-quarter earnings results and an optimistic upward revision in corporate guidance. The company reported an increase in sales and net income compared to the previous year, projecting confidence for the remainder of 2025. These positive events coincided with a broader market uptick, including a strong U.S. jobs report and potential trade talk optimism, both bolstering the S&P 500's...

Simply Wall St. 12 days ago

IDXX
+0.06%
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...

IDEXX Laboratories Inc (IDXX) reports robust revenue growth driven by diagnostics and consumables, despite facing headwinds in clinical visits and foreign exchange impacts.

GuruFocus.com 13 days ago

IDXX
+0.06%
IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market

IDEXX delivers year-over-year earnings and revenue growth in the first quarter of 2025.

Zacks 13 days ago

IDXX
+0.06%
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks 13 days ago

IDXX
+0.06%
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Simply Wall St. 13 days ago

IDXX
+0.06%
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

Idexx (IDXX) delivered earnings and revenue surprises of 1.37% and 1.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 13 days ago

IDXX
+0.06%
Idexx: Q1 Earnings Snapshot

WESTBROOK, Maine (AP) — Idexx Laboratories Inc. IDXX) on Thursday reported first-quarter profit of $242.7 million. On a per-share basis, the Westbrook, Maine-based company said it had profit of $2.96.

Associated Press Finance 14 days ago

IDXX
+0.06%
IDEXX Laboratories Announces First Quarter Results

WESTBROOK, Maine, May 01, 2025--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results.

Business Wire 14 days ago

IDXX
+0.06%
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?

MedTech bigwigs, such as CVS, HOLX and IDXX, are set to post their quarterly results tomorrow. Can they deliver on expectations?

Zacks 14 days ago

HOLX

IDXX
+0.06%

CVS
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth

Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 15 days ago

IDXX
+0.06%
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 15 days ago

IDXX
+0.06%
Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Besides Wall Street's top -and-bottom-line estimates for Idexx (IDXX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.

Zacks 15 days ago

IDXX
+0.06%
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 20 days ago

IDXX
+0.06%
Idexx Laboratories price target lowered to $475 from $535 at BofA

BofA lowered the firm’s price target on Idexx Laboratories (IDXX) to $475 from $535 and keeps a Neutral rating on the shares. Heading into Q1 earnings, the firm says sentiment on its animal health coverage “skews generally negative,” with a number of broader market and company-specific headwinds. The firm sees limited near-term catalysts to drive estimates higher beyond improved foreign exchange rates, so it thinks shares will remain capped near current levels, the analyst added in a preview for

TipRanks 22 days ago

IDXX
+0.06%
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?

IDEXX Laboratories' first-quarter 2025 performance is expected to have benefited from a strong execution against strategic priorities.

Zacks 23 days ago

IDXX
+0.06%
IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains?

IDEXX (IDXX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Zacks last month

IDXX
+0.06%

Performance Overview

Return	IDXX	S&P 500 (^GSPC)
YTD	+23.21%	+0.19%
1-Year	-2.24%	+12.31%
3-Year	+40.65%	+46.44%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IDEXX Laboratories, Inc. (IDXX)

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX)

Idexx Laboratories price target raised to $460 from $420 at Stifel

IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS

IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ...

IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market

Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics

Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist?

Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates

Idexx: Q1 Earnings Snapshot

IDEXX Laboratories Announces First Quarter Results

Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?

Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth

Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term

Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics

Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth

Idexx Laboratories price target lowered to $475 from $535 at BofA

IDXX Gears Up for Q1 Earnings: What to Expect From the Stock?

IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains?

Performance Overview